Hong-Wei Sun

5PUBLICATIONS
13CO-AUTHORS
Molecular targetsInnate immunityTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 25, 2024
RIG-I is an intracellular checkpoint that limits CD8+ T-cell antitumour immunity.

Xiaobing Duan, Jiali Hu, Yuncong Zhang

|Jan 08, 2021
Reprogramming immunosuppressive myeloid cells by activated T cells promotes the response to anti-PD-1 therapy in colorectal cancer.

Jing Chen, Hong-Wei Sun, Yan-Yan Yang

|Aug 08, 2019
Immunosuppressive Immature Myeloid Cell Generation Is Controlled by Glutamine Metabolism in Human Cancer.

Wen-Chao Wu, Hong-Wei Sun, Jing Chen

Pageof 1